{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:57:12Z","timestamp":1789419432551,"version":"build-2803163510"},"reference-count":46,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Single-subject voxel-based morphometry (VBM) is a powerful technique for reader-independent detection of brain atrophy in structural magnetic resonance imaging (MRI) to support the (differential) diagnosis and staging of neurodegenerative diseases in individual patients. However, VBM is sensitive to the MRI scanner platform and details of the acquisition sequence. To mitigate this limitation, we recently proposed and\n                      <jats:italic>technically<\/jats:italic>\n                      validated a convolutional neural network (CNN)-based VBM which does not rely on a normative reference database.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Clinical validation of CNN-based VBM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      CNN-based VBM was compared with conventional VBM based on a mixed-scanner normative database in 227 consecutive patients (66.0\u2009\u00b1\u20099.6 years, 53.3% female) with suspected dementing neurodegenerative disease. VBM maps were interpreted visually by two experienced readers, first with respect to the presence of any neurodegenerative disease, then for the differentiation between Alzheimer's disease (AD)-typical and non-AD atrophy patterns. A Likert 6-score was used for both tasks. Simultaneously acquired positron emission tomography (PET) with\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose (FDG) served as reference standard.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Repeated-measures ANOVA revealed a significant impact of the VBM method on the visual detection of any neurodegenerative disease (p\u2009&lt;\u20090.001). Balanced accuracy\/sensitivity\/specificity were 80.4\/86.3\/74.5% for CNN-based VBM versus 75.7\/79.5\/71.8% for conventional VBM. Differentiation between AD and non-AD typical atrophy patterns did not differ between both VBM methods (p\u2009=\u20090.871).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CNN-based VBM provides clinically useful accuracy for the detection of neurodegeneration-suspect atrophy with higher sensitivity than conventional VBM with a mixed-scanner normative reference database and without compromising specificity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13872877241304607","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T01:56:43Z","timestamp":1736733403000},"page":"542-551","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical validation of artificial intelligence-based single-subject morphometry without normative reference database"],"prefix":"10.1177","volume":"103","author":[{"given":"Dennis M","family":"Hedderich","sequence":"first","affiliation":[{"name":"Department of Neuroradiology, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9911-5478","authenticated-orcid":false,"given":"Roland","family":"Opfer","sequence":"additional","affiliation":[{"name":"jung diagnostics GmbH, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9963-4588","authenticated-orcid":false,"given":"Julia","family":"Kr\u00fcger","sequence":"additional","affiliation":[{"name":"jung diagnostics GmbH, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5012-9406","authenticated-orcid":false,"given":"Lothar","family":"Spies","sequence":"additional","affiliation":[{"name":"jung diagnostics GmbH, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Yakushev","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Klinikum rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0945-0724","authenticated-orcid":false,"given":"Ralph","family":"Buchert","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,1,12]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"e_1_3_6_3_2","first-page":"535","article-title":"NIA-AA Research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack CR","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, et al. NIA-AA Research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement 2018; 14: 535\u2013562.","journal-title":"Jr."},{"key":"e_1_3_6_4_2","first-page":"539","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack CR","year":"2016","unstructured":"Jack CR Jr., Bennett DA, Blennow K, et al. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 2016; 87: 539\u2013547.","journal-title":"Jr."},{"key":"e_1_3_6_5_2","unstructured":"Revised Criteria for Diagnosis and Staging of Alzheimer's Disease: Alzheimer's Association Workgroup. Draft Body Text as of October 9 2023. https:\/\/alz.org\/media\/Documents\/scientific-conferences\/Clinical-Criteria-for-Staging-and-Diagnosis-for-Public-Comment-Draft-2.pdf"},{"key":"e_1_3_6_6_2","article-title":"Disease-modifying treatments and their future in Alzheimer's disease management","volume":"16","author":"Smith B","year":"2024","unstructured":"Smith B, Ownby RL. Disease-modifying treatments and their future in Alzheimer's disease management. Cureus 2024; 16: e56105.","journal-title":"Cureus"},{"key":"e_1_3_6_7_2","unstructured":"National Institute for Health and Care Excellence. Dementia: assessment management and support for people living with dementia and their carers. https:\/\/www.nice.org.uk\/guidance\/ng97 (2018)."},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00115-023-01492-6"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-023-02215-8"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306285"},{"key":"e_1_3_6_11_2","unstructured":"S3-Leitlinie Demenzen Version 4.0 vom 28.11.2023. DGN e.V. & DGPPN e.V. 2023."},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-310090"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.05.024"},{"key":"e_1_3_6_14_2","first-page":"219","article-title":"Neuroimaging in Dementia","volume":"29","author":"Risacher SL","year":"2023","unstructured":"Risacher SL, Apostolova LG. Neuroimaging in Dementia. Continuum (Minneap Minn) 2023; 29: 219\u2013254.","journal-title":"Continuum (Minneap Minn)"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06602-0"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-021-02746-3"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102549"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2009.11.006"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2011.02.012"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2015.12.031"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2018.08.008"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.24038"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.2000.0582"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-10356-1"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-10438-0"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20190365"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-019-02188-y"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.971863"},{"key":"e_1_3_6_29_2","first-page":"1238","article-title":"A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET","volume":"36","author":"Minoshima S","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36: 1238\u20131248.","journal-title":"J Nucl Med"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2007.07.007"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/eb-2012-100645"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1390"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-020-00304-z"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-024-03304-3"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102453"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263194"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2021.01.002"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.13.12363"},{"key":"e_1_3_6_39_2","first-page":"594","article-title":"Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging","volume":"45","author":"Silverman DH","year":"2004","unstructured":"Silverman DH. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med 2004; 45: 594\u2013607.","journal-title":"J Nucl Med"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022534709672"},{"key":"e_1_3_6_41_2","first-page":"119","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack CR","year":"2010","unstructured":"Jack CR Jr., Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010; 9: 119\u2013128.","journal-title":"Jr."},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00785-9"},{"key":"e_1_3_6_43_2","first-page":"1238","article-title":"A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET","volume":"36","author":"Minoshima S","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36: 1238\u20131248.","journal-title":"J Nucl Med"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.198.3.8628880"},{"key":"e_1_3_6_45_2","unstructured":"Arbizu J Morbelli S Minoshima S et al. SNMMI procedure standard\/EANM practice guideline for brain [18F]FDG PET imaging version 2.0. DOI: snmmi.org\/Web\/Clinical-Practice\/Procedure-Standards\/Standards\/Brain\u201318F-FDG-PET-Imaging-2-0-guideline.aspx."},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.24143"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120344"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877241304607","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877241304607","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877241304607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:27Z","timestamp":1777370967000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877241304607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1177\/13872877241304607"],"URL":"https:\/\/doi.org\/10.1177\/13872877241304607","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}